IV Iron Dextran Cost-Effective for Managing Iron-Deficiency Anemia
TUESDAY, Jan. 13, 2026-- Intravenous (IV) iron dextran is the most cost-effective strategy for managing iron-deficiency anemia (IDA) in women with heavy menstrual bleeding (HMB), according to a study published online Jan. 8 in Blood...
Read more »